Asia-Pacific Health Industries Newsletter - July 2014

PwC’s Global Health Industries network is pleased to present you with its 11th issue of the Asia-Pacific Health Industries Newsletter.

In this edition we highlight a number of recent developments that are of direct interest to Pharmaceutical & Life Sciences companies and healthcare organisations including:

  • Changes in China’s compliance environment regarding disclosure regime with respect to the ethical obligations of health care professionals and institutions.
  • Developments in pricing in China.
  • Deals in Korea and India’s pharmaceutical industries.
  • Digital Health and Big Data.
  • Tax developments and changes across different areas: company tax rate and R&D tax offsets in Australia; new ordinance for Hong Kong corporate amalgamations; tax on M&A activities and restructuring strategies in China; update on wholly foreign invested medical institutions in China; and 2014 Budget changes in Singapore.

Contact us

Michael Swanick
Global Pharmaceutical and life sciences Leader
Tel: +1 (267) 330 6060

Douglas Strang
Global Pharmaceutical and life sciences Advisory Leader
Tel: +1 (267) 330 3045

Erik Bouwman
Tel: +31 (0)88 792 63 22

Follow us